1. Home
  2. FAX vs ARCT Comparison

FAX vs ARCT Comparison

Compare FAX & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FAX
  • ARCT
  • Stock Information
  • Founded
  • FAX 1986
  • ARCT 2013
  • Country
  • FAX United States
  • ARCT United States
  • Employees
  • FAX N/A
  • ARCT N/A
  • Industry
  • FAX Investment Managers
  • ARCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FAX Finance
  • ARCT Health Care
  • Exchange
  • FAX Nasdaq
  • ARCT Nasdaq
  • Market Cap
  • FAX 629.1M
  • ARCT 487.0M
  • IPO Year
  • FAX N/A
  • ARCT N/A
  • Fundamental
  • Price
  • FAX $15.50
  • ARCT $15.88
  • Analyst Decision
  • FAX
  • ARCT Strong Buy
  • Analyst Count
  • FAX 0
  • ARCT 8
  • Target Price
  • FAX N/A
  • ARCT $61.00
  • AVG Volume (30 Days)
  • FAX 833.6K
  • ARCT 405.9K
  • Earning Date
  • FAX 01-01-0001
  • ARCT 03-06-2025
  • Dividend Yield
  • FAX 12.09%
  • ARCT N/A
  • EPS Growth
  • FAX N/A
  • ARCT N/A
  • EPS
  • FAX N/A
  • ARCT N/A
  • Revenue
  • FAX N/A
  • ARCT $160,399,000.00
  • Revenue This Year
  • FAX N/A
  • ARCT $7.33
  • Revenue Next Year
  • FAX N/A
  • ARCT $4.71
  • P/E Ratio
  • FAX N/A
  • ARCT N/A
  • Revenue Growth
  • FAX N/A
  • ARCT N/A
  • 52 Week Low
  • FAX $2.33
  • ARCT $14.30
  • 52 Week High
  • FAX $2.84
  • ARCT $45.00
  • Technical
  • Relative Strength Index (RSI)
  • FAX 57.14
  • ARCT 41.74
  • Support Level
  • FAX $15.40
  • ARCT $16.03
  • Resistance Level
  • FAX $15.60
  • ARCT $17.95
  • Average True Range (ATR)
  • FAX 0.18
  • ARCT 1.29
  • MACD
  • FAX 0.06
  • ARCT -0.07
  • Stochastic Oscillator
  • FAX 79.10
  • ARCT 10.29

About FAX abrdn Asia-Pacific Income Fund Inc.

Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities, and others.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

Share on Social Networks: